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Abstract
One of the first ATP-dependent chromatin remodeling complexes was first identified and 
characterized over ten years ago. Since then, the number of distinct ATP-dependent 
chromatin remodeling complexes and the variety of roles they play in nuclear processes 
have become dizzying (Flaus and Owen-Hughes 2003; Lusser and Kadonaga 2003; 
Martens and Winston 2003 ; Vaquero et al. 2003 ; Dirscherl 2004). Some of the processes 
include transcription, replication, repair, recombination, and sister chromatid cohesion. 
The SWI/SNF-related ATP-dependent remodelers are divided into a number of 
subfamilies, all related by the SWI2/SNF2 ATPase at their catalytic core. In nearly every 
species where researchers have looked for them, one or more members of each subfamily 
have been identified. Here I have investigated the ATP dependent chromatin remodeler 
ISWI. I have shown that Xenopus ISWI, which is in its own subfamily, has a critical 
function in developing neural tissue. Whole mount in situ hybridization shows ISW I 
localized in neural tissue including the eye and developing neural tube. Injection of 
antisense ISW I RNA, morpholino oligonucleotides or dominant-negative ISW I mutant 
mRNA into fertilized eggs misregulates genes involved in patterning and development, 
such as BMP4 and Sonic hedgehog (Shh), and ISWI binds to the BMP4  gene in vivo. 
Partial inhibition of ISWI function results in aberrant eye development and the formation 
of cataracts. These data suggest a critical role for ISWI chromatin remodeling complexes 
in neural development.
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Chapter 1 
Introduction
The eukaryotic nucleus houses DNA, the genetic material of the organism. DNA 
is the blueprint for making thousands of different molecules in the body. In order for a 
functional product to be produced DNA must first be transcribed into RNA and then 
translated into protein (figure 1). The resulting proteins have many functions in the body, 
including structural and enzymatic roles.
The nucleus of a mammalian cell averages approximately 10 |^m in diameter, 
however, it houses over 2 meters of DNA. This is possible through complex interactions 
that condense the DNA down into tight coils. The first step in compaction is the winding 
of the DNA around proteins called histones. This DNA-protein complex is called a 
nucleosome and is repeated over and over again. The nucleosome consists of 146 bp of 
DNA wrapped nearly two times around a core histone octamer that consists of two copies 
each of histone H2A, H2B, H3 and H4. The linker histone HI interacts with the 
nucleosomal core as well as linker DNA. The nucleosome is the core repeating subunit 
of “chromatin”, the term used to describe the entire protein-DNA network in the nucleus 
(figure 2). Negatively charged DNA and positively charged histones attract each other 
through electrostatic forces. The nucleosomes then wind around each other furthering the 
compaction into a 30 nm chromatin fiber (figure 3).
GENE:
mRNA:
Outline of Gene Expression
ATGAGTAACGCG n o n - t e m p l a t e  s t r a n d  
TACTCATTGCGC t e m p l a t e  s t r a n d
TRANSCRIPTION
AUGAGUAACGCG
TRANSLATION
PROTEIN: MET-SER-ASN-ALA
Figure 1.1 Central dogma. DNA is transcribed into RNA then translated into protein.
3Figure 1.2 The nucleosome. 146 bp of DNA is wound around an octamer of histone proteins and is called a 
nucleosome (Arents and Moudrianakis 1993).
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Figure 1.3 Condensation of DNA. DNA is wound around the octomer of core histones to from 
the nucleosome, which is then further condensed to fit inside the nucleus of a cell, (taken from 
Felsenfeld and Groudine Nature 2003)(Felsenfeld and Groudine 2003)
The question is that with all of this compaction, how is our DNA accessed by 
transcription factors and enzymes to be transcribed into RNA? It is the intricate 
interactions between chromatin remodelers and chromatin that allow DNA to be available 
for transcription. Despite many years of investigation by numerous scientists, 
transcriptional regulatory control remains an intensely explored and continuously 
evolving field of research. Transcriptional regulation is dependent not only on 
transcription factor activation but is also heavily dependent on chromatin structure. In 
addition to transcription factor activation and chromatin changes, there is an expanding 
array of additional histone modifications that fine tune transcriptional regulation for the 
specific conditions of a particular cell type, organ system, and developmental stage.
In the eukaryotic nucleus there are several levels of chromatin compaction. Arrays 
of nucleosomes fold into higher order structures that range from the 30 nm diameter 
chromatin filament during interphase to the highly compacted metaphase chromosomes 
during mitosis. The nucleosome can be considered a transcriptional repressor because it 
impedes the access of transcription factors to their target sites. An early step in gene 
activation involves alteration of the nucleosome structure or “remodeling” at active 
promoters and enhancers, which then allows for binding of transcription factors.
Every nuclear process that requires access to DNA functions in the context of 
chromatin. The cell has developed optimal use of chromatin as the substrate for DNA- 
directed processes. For instance, histones are subject to a number of covalent
modifications such as acetylation, phosphorylation, methylation and ubiquitination 
(figure 4). These modifications serve to alter the biochemical properties of chromatin as 
well as to provide signals that regulate the activities of other factors, known as the 
“histone code.” A combination of chromatin remodeling enzymes and histone modifying 
enzymes establish a steady level of transcriptional control in all eukaryotes.
In addition to covalent histone modification, cells also use ATP-dependent 
chromatin remodeling as a means of controlling access to DNA. This remodeling is 
performed by multi-subunit complexes that use the energy of ATP hydrolysis to disrupt 
histone-DNA interactions (figure 5). In the next chapter we will discuss the rather large 
SW I2/SNF2 superfamily of ATP-dependent chromatin remodelers in detail.
Imitation Switch (ISWI) is a subfamily of the SW I2/SNF2 superfamily. ISWI is a 
common subunit of many different complexes. The ISWI subunit is present in at least 7 
complexes in mammals, three in Drosophila, four in Xenopus, and four in budding yeast. 
One ISW I homolog has also been found in Arabidopsis. The extreme diversity of ISWI 
complexes within the same organism as well as homology between organisms suggests a 
wide range of essential functions. One example is ISW I’s association with WSTF 
(W illiams syndrome transcription factor) in the WICH complex. W STF codes for a 
transcription factor which is deleted (along with several other genes) in the genetic 
disorder W illiams-Buernes syndrome. This syndrome is characterized by severe 
developmental delays, unusual facial appearances and specific cognitive and personality
7Active:
Histoneacetylation Histonedeacetylation
Repressed:
Figure 1.4 Histone covalent modification. HAT’s and HDAC’s are able to change the association of DNA 
with histones, allowing for genes to be active or repressed (adapted from (Weaver 2002)
T ran sc rip tio n  factors
C h rom atin  rem odeling I j com plex
ATP
Figure 1.5 ATP-dependent chromatin remodeling. The multisubunit complexes of ATP-dependent 
chromatin remodelers use the power of ATP hydrolysis to move histones to repress or activate gene 
transcription. This came from a recent review on remodelers, have to find out which one (adapted from 
http://faculty.jsd.claremont.edu/jarmstrong/researchint.htm).
profiles. With W STF missing, the WICH complex cannot be formed; this loss may be 
responsible for several of the defects these patients exhibit. Therefore, by investigating 
the common subunit of all of these complexes we may not only be able to understand the 
basic biochemical nature of ISW I’s chromatin remodeling activities but also discover 
how deletion of this subunit, which is present in so many complexes, may alter 
developmental patterns in organisms.
This thesis describes the characterization of the expression pattern and function of 
the ISWI subunit in the development of Xenopus laevis. Through in situ hybridization I 
have shown which tissues express ISW I mRNA throughout different developmental 
stages. I have used microinjection of antisense ISW I RNA, anti-ISWI morpholino or 
dominant-negative ISWI mutants to explore the effects of a nonfunctional or absent ISWI 
protein. Because ISWI is a subunit in at least four different Xenopus ATP-dependent 
chromatin remodeling complexes, I also examined the expression pattern of specific 
mRNAs that are potential targets for ISW I-dependent remodeling. I also tested direct 
DNA binding by ISWI protein using chromatin immunoprecipitation (ChIP). With these 
experiments I have begun to establish the critical role of ISWI in the developing Xenopus 
laevis embryo.
10
Chapter 2 
The SWI2/SNF2 subfamily
At least 7 distinct subfamilies of the SWI2/SNF2 superfamily have been found to 
date. These families include SNF2, CHD1, IN 080, CSB, RAD54, DDM1 and Imitation 
Switch (ISWI) (Lusser and Kadonaga 2003). Proteins from each of these subfamilies 
have been found to participate a wide array of ATP-dependent chromatin remodeling 
processes such as transcriptional activation and repression, nucleosome spacing or 
sliding, replication, repair, recombination and nucleosomal assembly. Next we will 
discuss the unique properties to all of these subfamilies.
The CHD family
The CHD subfamily, like all members of the SWI2/SNF2 superfamily, contains a 
conserved ATPase domain. However, these family members also contain a chromo 
(chromatin organization modifier) domain and a DNA binding domain. Chromo domains 
are found in a number of proteins, including many that have the ability to interact with 
heterochromatin. Chromo domains have been found to act as recognition motifs for 
methylated lysine 9 of H3 (Lachner et al. 2001; Nakayama et al. 2001). Chromo domains 
have also been shown to interact with RNA as well as to self associate with one another. 
CHD complexes have been found in many organisms including yeast, human, Drosophila 
and Xenopus.
In the budding yeast S. cerevisiae there is only one CHD protein, C hdl. C hdl 
purification shows that it does not associate with other proteins in a complex, but elutes
from sizing columns at double its molecular weight, indicating that it may exist as a 
dimer (Neely and Workman 2002). chdl null mutants are viable; however, a chdl/sw i2  
double mutant is synthetically lethal suggesting that the C hdl and SW I/SNF complexes 
may have overlapping functions (Tran et al. 2000). Likewise, fission yeast 
(Schizosaccharomyces pombe) contain only one CHD family member, Hrpl , 
characterized by a chromodomain, a Myb-like telobox-related DNA-binding domain and 
a SW I2/SNF2 ATPase domain (Jin et al. 1998).
In humans many complexes contain a CHD family member and contain ATP- 
dependent nucleosome remodeling activities. NURD (aka NuRD and NRD) was 
discovered and named in three separate laboratories and contains both ATP-dependent 
remodeling and histone deacetylase activity (Tong et al. 1998; Xue et al. 1998; Zhang et 
al. 1998). CHD4/Mi-2|3 and CHD 3/M i-2a are highly related proteins that were identified 
as autoantigens in the human disease dermatomyositis, and provide the ATP-dependent 
chromatin remodeling activity of NURD. There has been no recent data indicating 
whether M i-2a and Mi-2|3 are in the same complex or exist in separate but related 
complexes (Neely et al. 2002; Bowen et al. 2004). Although both appear to present in the 
same tissues, Mi-2|3 seems to be the more abundant isoform to elute with the other 
subunits of NURD (Tong et al. 1998). M i-2a elutes from phosphocellulose fractionation 
at a separate salt fraction as well as the same salt fraction as Mi-2|3. The M i-2a fraction 
that does not elute with NURD does retain its HDAC function suggesting M i-2a may 
have a unique function in an alternative complex or alone yet to be discovered (Schultz et
Shultz et al. (2001) also identified a domain unique to the M i-2a isoform known 
as the KRAB domain. The KRAB domain is a highly conserved domain, which displays 
potent. DNA-binding-dependent repression of transcription that requires the KAP-1 co­
repressor. This finding agrees with the current models, which predict the NURD complex 
functions primarily in transcriptional repression. Both M i-2a and Mi-2|3 associate with 
many other proteins within the NURD complex including: histone deacetylases (HDAC1 
& 2), Rb-associated proteins (RbAp48 & 46), metastasis associated proteins (MTA1 & 2) 
and the MBD protein family, which contain the methyl-CpG binding domain (Tong et al. 
1998; Xue et al. 1998; Zhang et al. 1998; Wang and Zhang 2001). Uniquely, all of the 
subunits of the NURD complex present heterogeneity at the protein and gene level, 
raising the possibility for specialization as different isoforms of each subunit are 
recruited.
In Xenopus a complex highly homologous to the NURD complex was isolated 
from egg extracts (Wade et al. 1998; Wade et al. 1999). This complex contains Rpd3, a 
histone deacelylase, and the Mi-2 ATPase. Other components include RbAp48/p46, 
M TA l-like, MBD3 and MBD3 LF (long form). One contrast to human NURD is that 
MBD3 in Xenopus NURD is able to target and bind methylated DNA, whereas human 
NURD cannot (Bowen et al. 2004).
Drosophila also contains a Mi-2 homolog named dMi-2 (Brehm et al. 2000). dMi- 
2 exists in a large complex, similar to its human and Xenopus counterparts, but this 
complex is not well characterized. It does contain dRpd3 and histone deacetylase activity; 
however, dM i-2’s ATPase activity is only stimulated by nucleosomes (Brehm et al. 2000)
dMi-2 was shown to have the ability to bind nucleosome cores (which presumably 
display no free DNA) and dMi-2 moves histone octamers in one direction in sliding 
assays suggesting it uses a unique mechanism of nucleosome mobilization (Brehm et al. 
2000).
The IN 080 family
The Ino80 complex in yeast is the most recently described chromatin remodeling 
complex and is referred to as Ino80.com (Shen et al. 2000). The Ino80 complex remodels 
chromatin, facilitates transcription in vitro, and displays ATP-dependent chromatin 
remodeling activity and in yeast it is known to be associated with chromosomes of 
dividing cells (Shen et al. 2000). The IN 0 80  gene from yeast forms a distinct subfamily, 
which has not yet been well characterized. Null mutants show not only hypersensitivity to 
alkylating agents and ultraviolet as well as ionizing radiations, but they also have defects 
in transcription (Ebbert 1999; Shen et al. 2000). Ino80 mutants in yeast have been shown 
to be hypersensitive to DNA damaging agents and to double strand breaks induced by the 
HO endonuclease through a specific interaction with the DNA-damage induced 
phosphorylated histone H2A (Morrison et al. 2004; van Attikum et al. 2004).
Ino80 has both Drosophila and human homologs. The IN 080  family was recently 
characterized in silico and was found to lack a SANT domain and a bromodomain; 
however, sequence alignments revealed that these proteins contain a conserved region 
beyond the seven motif ATPase domain (Bakshi et al. 2004). This domain was found in 
all homologs of IN 080, including mouse, human, Drosophila, yeast and plants (Bakshi et 
al. 2004). All family members analyzed contained what is now referred to as a DBINO
(DNA Binding IN 080) domain. This domain is located in the N-terminus upstream of 
the ATPase domain and consists of 126 amino acids. Due to the high incidence of 
arginine and lysine, which are two positively charged amino acids, this site was deemed a 
putative DNA binding domain. In support of this, Shen et al. reported a detailed study on 
the role of actin-related protein (ARP) complex in yeast. They found that when a 326 
amino acid region in the N-terminus was deleted there was a loss of DNA binding 
activity. This proved interesting because the DBINO domain maps to this region (Bakshi 
et al. 2004). Ino80 was purified as a complex with twelve associated proteins. Actin 
(A ctl) and three other actin-related proteins (Arp4, Arp5, Arp8) were found to co-purify 
with IN 080. Additionally, two helicase proteins, R vbl and Rvb2, were identified. The 
other 5 proteins have not been identified to date, but are present in equal amounts.
The SNF2 family
The SNF2 subfamily includes the yeast Swi2/Snf2 subunit of the SW I/SNF 
complex, the yeast Sthl subunit of the RSC complex, and the Drosophila  Brahma, human 
BRG1 and hBRM subunits of the SWI/SNF-related complexes in Drosophila and 
humans. SNF2 subfamily members contain a bromodomain in addition to the ATPase 
region.
Mammalian SWI/SNF contains one of two ATPases, BRM and BRG1 along with 
variable subunit composition of BRG1-associated factors (BAFs). BRG1 and BRM are 
highly homologous ATPases, yet they appear to direct very different cellular pathways. 
Gene knockout studies in mice have demonstrated that homozygous inactivating 
mutations in BRG1 are embryonic lethal whereas BRM-inactivated mice are mainly
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characterized as having excess body weight (Reyes et al. 1998; Bultman et al. 2000). 
BRG1 and BRM activities are partially redundant but they have different expression 
profiles. BRG1 protein levels are relatively consistent in all cells whereas BRM protein 
concentrations increase during cellular differentiation (Wang et al. 1996). A variety of 
human malignancies are associated with mutations in BRG1, but not BRM, suggesting 
that a loss of function of certain SW I/SNF complexes may contribute to tumorigenesis 
(Klochendler-Yeivin et al. 2002). BRG1 and BRM interact specifically with different 
classes of regulatory proteins. BRG1 but not BRM functions with zinc finger proteins 
(ZFP) and recruits them to specific chromatin sites (Kadam and Emerson 2003). Either 
BRG1 or BRM, but not both, interact with different SW I/SNF-responsive promoters, 
supporting the divergence of function for these two homologs. The BRM ATPase is 
expressed at high levels in differentiating cells, but the functional role is not understood. 
Kadem et al. (2003) found that two components of the Notch pathway associate with 
BRM not BRG1. The Notch pathway controls cell fate commitment in a broad range of 
developmental pathways. BRG1-containing SW I/SNF is involved in regulating genes 
induced by cytokine pathways through interferon a  or y (Liu et al. 2002; Pattenden et al. 
2002). A common feature of the BRG1/BRM target genes is that they promote cellular 
differentiation and may have evolved to counter the cellular demands of higher 
eukaryotes. BRG1 and BRM have been recently shown in cell culture to be required for 
estrogen antagonist-mediated growth suppression through the estrogen receptor, which 
suggest that BRG1 and BRM may be major cellular targets for estrogen antagonists, 
which are potentially important targets for breast cancer therapy (Wang et al. 2004).
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BRM and BRG1 have been implicated as possible prognostic indicators for non-small 
cell lung cancer (Fukuoka et al. 2004).
The essential S th lp  is the protein most closely related to Snf2p/Swi2p in 
Saccharomyces cerevisiae. S th lp  purified from yeast has a DNA-stimulated ATPase 
activity required for its function in vivo (Haynes et al. 1992; Laurent and Carlson 1992; 
Tamkun et al. 1992; Jeanmougin et al. 1997). S th lp  is the catalytic component of a 
multiprotein complex capable of ATP-dependent remodeling of the structure of 
chromatin (RSC). Three sth l temperature-sensitive mutations map to the highly 
conserved ATPase domain and have cell cycle and non-cell cycle phenotypes, suggesting 
multiple essential roles for S th lp  (Du et al. 1998). The S th lp  bromodomain is required 
for wild-type function; deletion mutants lacking portions of this region are therm o­
sensitive and arrest with highly elongated buds and 2C DNA content, indicating 
perturbation of a unique function (Du et al. 1998). The pleiotropic growth defects of sth l-  
ts mutants imply a requirement for S th lp  in a general cellular process that affects several 
metabolic pathways. Significantly, an s th l-ts allele is synthetically sick or lethal with 
previously identified mutations in histones and chromatin assembly genes that suppress 
svW/sn/mutations, suggesting that RSC interacts differently with chromatin than 
SW I/SNF (Du et al. 1998). These results provide a framework for understanding the 
ATP-dependent RSC function in modeling chromatin and its connection to the cell cycle.
Drosophila has only one Swi2/Snf2 family member called Brahma (BRM) 
(Dingwall et al. 1995; Papoulas et al. 1998). The BRM complex is composed of 
approximately eight proteins, which are referred to as BAPs (BRM-associated proteins).
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These proteins include the trithorax group (trxG), M oria/Bapl55 (MOR), OSA/Eyelid 
and S nrl, Bap60, Bap55, Bapl 11, (3-actin/Bap47 and BAP74 (Dingwall et al. 1995; 
Crosby et al. 1999; Collins and Treisman 2000; Kal et al. 2000). The Drosophila BRM 
complex was identified on the basis of its requirement for the maintenance of homeotic 
(HOM) gene expression (Tamkun 1995; Elfring et al. 1998), and is essential for proper 
development. Mutations in several BRM complex genes give rise to a broad range of 
developmental defects (Tamkun 1995).
The RAD54 family
Rad54 and its relation to the SW I2/SNF2 superfamily was first analyzed in yeast. 
Since then other homologs in yeast and human have been identified. The family 
members of the RAD54 subfamily include RAD54, ATRX and ARIP4 (Lusser and 
Kadonaga 2003). Each homolog has been implicated in unique cellular activities ranging 
from homologous recombination of double strand breaks to transcription.
The RAD54 gene plays an important role in recombination and DNA double 
strand break repair in Saccharomyces cerevisiae and in humans. In vitro, Rad54 interacts 
with R ad51 and stimulates DNA strand exchange promoted by R ad51 protein. Rad54 is a 
SW I2/SNF2-related protein that possesses double-stranded DNA-dependent ATPase 
activity and changes DNA topology in an ATP hydrolysis-dependent manner (Alexeev et 
al. 2003). Rad54 catalyzes bidirectional nucleosome redistribution by sliding 
nucleosomes along DNA (Alexeev et al. 2003). There are two RAD54-homologous genes 
in human cells, hRAD54 and RAD54B. Point mutations in these human genes have been 
found in tumors. These tumor-associated mutations map to conserved regions of the
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hRad54 and hRad54B proteins. Equivalent mutations were introduced with site directed 
mutagenesis into the Saccharomyces cerevisiae RAD54 gene to explore the effects of 
these mutations (Smirnova et al. 2004). One mutant, rad54-G484R, showed sensitivity to 
DNA-damaging agents and reduced homologous recombination rates, indicating a loss of 
function. Purified rad54-G484R mutant protein retained the ability to bind DNA and 
interact with Rad51, but it was nearly devoid of ATPase activity. Two other mutants, 
rad54-N616S and rad54-D442Y, were not sensitive to genotoxic agents and behaved like 
the wild type allele in homologous recombination assays (Smirnova et al. 2004). This 
suggests that the tumor phenotype may be enhanced by the enhanced genomic instability 
of tumor cells lacking RAD54 function.
The ATRX protein was first identified in patients with ATRX syndrome. 
Mutations in the ATRX gene cause several X-linked mental retardation syndromes, 
which consist of the following phenotypes: facial dysmorphism, urogenital defects, and 
a-thalassaem ia (Gibbons et al. 2000). However, until recently, the ATRX protein had not 
been biochemically characterized. ATRX was first thought to have ATP-dependent 
activity due to the sequence homology to SWI/SNF2. ATRX contains an 
ATPase/helicase motif as well as a plant homeodomain-like zinc finger (Villard et al. 
1997), both of which have been found in molecules that modify chromatin structure. 
ATRX has also been found in nuclear extracts and is a protein of about 280 kDa (Berube 
et al. 2002). ATRX localizes at pericentromeric heterochromatin (McDowell et al. 1999) 
and has been identified in yeast two-hybrid screens to interact with the heterochromatin 
protein HP1 as well as a polycomb group protein EZH2 (Cardoso et al. 1998; McDowell
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et al. 1999). Mutations in ATRX have been correlated with changes in DNA methylation 
patterns at several genomic loci (Gibbons et al. 2000). ATRX is now known to form a 
complex with a transcription cofactor, Daxx, and this complex displays chromatin- 
remodeling activities (Xue et al. 2003).
Recently a novel ATP-dependent chromatin remodeler has been characterized by 
Rouleau et al (2002) that belongs to the SNF2 family and RAD54 subfamily of proteins. 
The protein was termed ARIP4 (androgen receptor interacting protein 4). ARIP4 
interacts with androgen receptors (AR) in vivo and in vitro. It generates super-helical 
torsion within linear DNA fragments in an ATP-dependent manner and it modulates AR- 
mediated transcription (Rouleau et al. 2002). ARIP4 mutants incapable of hydrolysis fail 
to alter DNA topology and lose the ability to activate AR-dependent transcription 
(Rouleau et al. 2002). These mutants also behave as trans-dominant negative regulators 
of AR function when expressed ectopically in transient transfection assays (Rouleau et al. 
2002).
The CSB family
The Cockayne Syndrome B (CSB) subfamily belongs to the Swi2/Snf2 family of 
DNA-dependent ATPases (CSB, Rad26). These proteins enable transcription-coupled 
repair (TCR). This form of DNA repair occurs on the transcribed strand so that 
transcription is not stalled at an error. The human disease Cockayne Syndrome (CS) is 
associated with a defect in TCR. The CSA and CSB (aka ERCC6) genes have been 
identified as uniquely affecting TCR in mammalian cells. A yeast gene with homology 
to the human CSB gene (RAD26) was isolated and sequenced (Huang et al. 1994; van
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Gool et al. 1994). Next a rad26 deletion mutant was created(van Gool et al. 1994). 
Consistent with the DNA repair deficiency observed in cultured cells from CS patients, 
the yeast rad26A  mutant lacks TCR activity (van Gool et al. 1994). Previous repair rates 
for the rad26A  mutant have all been determined in one genetic background, W303-1B. 
Recently a deletion of RAD26 in three other strains of different genetic backgrounds was 
carried out and their ability to carry out TCR was examined by Gregory et al. (2001). 
Surprisingly, no defect was observed in TCR of an expressed gene in these new rad26A 
mutants. Notably, deletion of RAD26 enabled expression from genes flanked by 6 
elements, 5 elements alter local chromatin structure and gene expression (Gregory and 
Sweder 2001). Suppression of 5 element phenotypes suggests a role for Rad26 in 
chromatin remodeling or transcription elongation. Gregory et al. suggested that these 
results implicate Rad26 (or CSB) to be necessary but not sufficient to enable TCR.
The DDM1 family
Deficient in DNA Methylation 1 (DDM1) protein is required to maintain the 
DNA methylation status of Arabidopsis thaliana. Methylation of cytosine residues in the 
genome is thought to be crucial for normal development in mammals as well as plants, 
frogs, and fish. DNA methylation is involved in the regulation of a diverse range of 
biological processes such as genomic imprinting and X-chromosome inactivation (Yeivin 
and Razin 1993; Razin and Shemer 1995). DDM1 is a member of the broad SW I2/SNF2 
protein family and is conserved in plants, yeast and mammals. No genes encoding 
D D M l-like proteins have been found in the two fully sequenced invertebrate genomes. 
Evolutionary analysis places the DDM1 subfamily close to ISWI and SNF2/SW I2 groups
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(Verbsky and Richards 2001). Previously it was unclear how DDM1 acts to maintain 
DNA methylation status, although it had been speculated that it could remodel chromatin. 
Brzeski et al. (2003) found that DDM1 is an ATPase stimulated by both naked and 
nucleosomal DNA. It binds to nucleosomes and promotes nucleosome repositioning in an 
ATP-dependent manner (Brzeski and Jerzmanowski 2003). This data indicated that 
DDM1 defines a novel class of chromatin-remodeling factors.
LSH (lymphoid specific helicase) is another member of the DDM1 subfamily.
LSH shows a preferential lymphoid expression pattern in adult mice and has been shown 
to be important for normal lymphoid development (Geiman et al. 1998; Geiman and 
Muegge 2000). A low expression of LSH has been found in multiple embryonic tissues 
suggesting a broader role for LSH in development (Geiman et al. 2001). LSH shares 
about 50% identity with DDM1 over the region containing the helicase domains 
(Jeddeloh et al. 1999). A recent study investigated the effect of LSH on genomic 
methylation patterns in mice. Based on LSH ’s presumed chromatin remodeling activity it 
was speculated that LSH may regulate chromatin accessibility for DNA 
methyltransferases. Because LSH protein expression correlates with S-phase of the cell 
cycle (Geiman and Muegge 2000), LSH may facilitate access of DNA methyltransferases 
to hemimethylated sites after replication occurs and thus co-operate to maintain 
methylation patterns. Alternatively, the presence of LSH may protect against demethylase 
activities (Jarvis et al. 1996; Ramchandani et al. 1999). Methylation of histone tails and 
CpG methylation are involved in determining heterochromatin structure, LSH has 
recently been reported to control both types of epigenetic modifications (Yan et al. 2003).
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Loss of LSH in mice results in accumulation of di- and tri-methylated histone 3 at lysine 
4 (H3-K4me) at pericentromeric DNA and other repetitive sequences (Yan et al. 2003). 
LSH is associated with pericentromeric heterochromatin and is be required for normal 
CpG methylation at pericentromeric sequences (Yan et al. 2003). LSH seems to be 
crucial for the formation of normal heterochromatin, which implies a role for LSH in the 
regulation of transcription and mitosis.
The ISWI Family1
The ISWI family of ATPases is distinguished from the other SNF2/SW I2-related 
subfamilies by the presence of SANT (SWI3, ADA2, N-CoR, TFIIIB) domains in the C- 
terminal half of the protein. The ISWI group was originally identified in Drosophila, 
from which three different ISWI-based remodeling complexes were purified: NURF 
(nucleosome remodeling factor), ACF (ATP-depdendent chromatin-assembly and - 
remodeling factor) and CHRAC (chromatin accessibility complex) (Becker et al. 1994; 
Tsukiyama et al. 1994; Tsukiyama et al. 1995; Tsukiyama and Wu 1995).
ISW I-based nucleosome-remodeling complexes have since been identified in 
yeast, Xenopus, Arabidopsis, and mammals. In yeast, two closely related ISWI proteins, 
Isw lp  and Isw2p, are present in four different complexes: Isw la, Isw lb, Isw2, and 
Isw2/yCHRAC (Tsukiyama et al. 1999; Vary et al. 2003; Iida and Araki 2004). ISWI 
protein is present in four distinct biochemical fractions in Xenopus oocytes (Guschin et 
al. 2000). Two of these ISWI-containing complexes are homologs of the ACF and
' This section is a modified version of a published review: Dirscherl, S. and Krebs, JE. (2004). "Functional diversity of ISWI complexes." Biochem Cell Biol. 82(4): 482-9.The complete publication is found in Appendix A.
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CHRAC complexes. A third complex is the WICH complex, a complex of ISWI and the 
Williams Syndrome Transcription Factor (WSTF) (Bozhenok et al. 2002). The fourth 
ISWI complex has not been characterized, and a Xenopus homolog of NURF has not 
been identified (Guschin et al. 2000). In mammals, two related ISWI homologs are 
encoded by the SNF2L  and SNF2H  genes. The SNF2H subunit has been found in a 
remarkable six different complexes. These include RSF (remodeling and spacing factor) 
(LeRoy et al. 1998; Loyola et al. 2003), hACF/W CRF (W STF-related chromatin 
remodeling factor) (Bochar et al. 2000; LeRoy et al. 2000), hWICH (Bozhenok et al. 
2002), hCHRAC (Poot et al. 2000), and NoRC (nucleolar remodeling complex) (Strohner 
et al. 2001). Finally, SNF2H has also been identified in a complex that also contains 
cohesin and subunits of the NuRD complex, a nucleosome remodeling and histone 
deacetylase complex containing the Mi-2 ATPase (a member of the CHD1 subfamily) 
(Hakimi et al. 2002). SNF2L has recently been identified as the catalytic subunit of 
human NURF (Barak et al. 2003). The first ISWI homolog in Arabidopsis, PIE1, has 
recently been identified (Noh and Amasino 2003), but has not yet been characterized 
biochemically.
The functional diversity of ISWI complexes is nearly as great as the sheer number 
of complexes performing these functions. In vivo functions attributed to ISWI complexes 
include transcriptional activation and repression, chromatin assembly, nucleosome 
spacing or sliding, replication through heterochromatin, maintenance of higher order 
chromatin structure, nuclear remodeling of somatic cells, and loading of cohesin 
complex. These different in vivo functions are summarized in table I, and are detailed
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below in the descriptions of specific complexes (Tsukiyama 2002). The mechanism of 
ISWI-dependent remodeling has also been extensively studied in vitro. These studies 
have been well-reviewed elsewhere (Langst and Becker 2001b; Becker and Horz 2002: 
Peterson 2002; Flaus and Owen-Hughes 2003; Lusser and Kadonaga 2003; van Holde 
and Yager 2003), and will only be briefly addressed here. The known subunit 
compositions of ISWI complexes are depicted schematically in figure 1. In the following 
sections, I have grouped the various ISWI complexes by homology of species and related 
in vivo functions.
Chromatin assembly and replication: ACF, CHRAC, RSF, WICH
Among the first ISWI complexes purified were the ACF and CHRAC complexes 
from Drosophila, which exhibit the ability to assemble nucleosomes into regularly spaced 
nucleosomal arrays (Ito 1997; Ito et al. 1997; Varga-W eisz et al. 1997). These 
complexes are closely related; ACF contains only ISWI and ACF1 (Ito et al. 1999), and 
CHRAC is essentially ACF plus two other subunits, CHRA C-14 and C H R A C -16 
(Corona et al. 2000). CHRAC-14 and CHRAC-16 contain histone fold domains and are 
conserved in mammalian (CHRAC-15 and CHRAC-17) and Xenopus (CHRAC-17) 
CHRAC (Guschin et al. 2000; Poot et al. 2000). Human CHRAC-15/17 has been shown 
to facilitate the in vitro nucleosome sliding activity of ACF-ISW I (Kukimoto et al. 2004). 
The chromatin assembly factor RSF, like ACF, is a small complex consisting of only two
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Table 2.1 In vivo functions of ISWI-containing complexes. (ACF/CHRAC complexes have in vitro
assembly/spacing functions, not all have been tested). Details and references are contained in the text.
Complex Organism # sub­units Subunits In vivo function(s)dACF Drosophila 2 ISWI and ACF1 Assembly/spacing
xACF Xenopus 3 ISWI, xA C Fl,p l75 Assembly/spacing
hACF Human 2 SNF2h and ACF1/WCRF180 Assembly/spacingyCHRAC Yeast 4 Isw2p, Itclp, Dpb4p, Dlslp Telomere positioneffect/heterochromatinstructuredCHRAC Drosophila 4 ISWI, ACF1, CHRAC14, CHRAC 16 Assembly/spacing
xCHRAC Xenopus 5 ISWI, p200, p70, p55 and CHRAC 17 Assembly/spacinghCHRAC Human 4 hSNF2H, hACFl, pl5 and pl 7 Assembly/spacingRSF Human 2 hSNF2H and Rsf-l/p325 Assembly/spacing
xWICH Xenopus 2 ISWI and WSTF Heterochromatin replication, transcriptionhWICH Human 2 SNF2H and WSTF Heterochromatin replication, transcriptionyISW la Yeast 2 Iswlp and Ioc3p Transcription repression (many genes)ISW lb Yeast 3 Iswlp, Ioc2p, Ioc4p Transcription elongation and terminationISW2 Yeast 2 Isw2p and Itclp Transcription repression (many genes), nucleosome slidingdNURF Drosophila 4 ISWI, p301, NURF-55, NURF-38 Transcription activation (heat shock and homeotic genes)hNURF Human 4 SNF2L, BPTF and RbAP46/48 Transcription activation (engrailed)NoRC Human 2 SNF2h and Tip5 rDNA repressionPIE 1 Arabidopsis 7 PIE1 and ? Transcription activation (FLOWERING LOCUS C)SNF2h/NuRD/cohesin
Human SNF2h, NuRD (Mi-2, HDAC1/2, MBD2/3, MTA1/2, RbAp46/48), cohesin (hRAD21, hSMCl/2, SA1/SA2)
sister chromatid cohesion
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Figure 2.1 Subunit compositions of ISWI complexes. Colors indicate homologous proteins. Drawings are not to scale and only reflect relative sizes of subunits. No specific subunit interactions or complex substructures are implied. Details are found in the text.
subunits, SNF2H and Rsf-l/p325 (LeRoy et al. 1998; Loyola et al. 2003). Thus far, RSF 
has only been identified in human cells. RSF can assemble and space chromatin in vitro , 
and, unlike ACF and CHRAC, does not require histone chaperones, because RSF 
performs histone-chaperone activity itself (Loyola et al. 2001). Despite these studies, 
which indicated that ISWI complexes could assemble properly spaced chromatin in vitro, 
for a long time no one found any role for these complexes in chromatin assembly in vivo. 
Recently, however, roles for ISWI complexes in replication have been described. Work 
from the laboratory of Patrick Varga-W eisz revealed a critical role in replication through 
heterochromatin for either the hACF or hCHRAC complex (Collins et al. 2002; de la 
Serna and Imbalzano 2002). These researchers showed that either RNAi-depeletion of 
ACF1 or the use of a mutant of ACF1 that cannot bind SNF2H specifically impairs the 
replication of pericentric heterochromatin in human cells. This effect can be reversed by 
adding of 5-aza-2-deoxycytidine, which inhibits DNA methylation and leads to 
decondensation of the heterochromatin. This work suggest that ACF/CHRAC plays a 
role, not in assembly of chromatin behind the replication fork, but rather in facilitating 
movement of the fork through dense heterochromatin.
Recent work in the Kadonaga laboratory indicates that Drosophila ACF/CHRAC 
complexes are required for proper chromatin assembly, particularly repressive chromatin 
structures (Fyodorov et al. 2004). Only 25% of Acf-null flies survived past the pupal 
stage; these survivors exhibited reduced nucleosome periodicity and reduced average 
nucleosomal spacing in bulk chromatin in vivo. Further, loss of Acf 1 resulted the loss of 
transcriptional silencing in pericentric heterochromatin and Polycomb-repressed
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chromatin, suggesting that ACF/CHRAC plays a key role in establishing or maintaining 
repressive chromatin. Acf 1-deficient embryos also exhibited a shortened S phase, 
possibly resulting from the lack of chromatin repression of DNA replication.
In contrast, depletion of ISWI from Xenopus egg extracts does not appear to affect 
the efficiency of either replication or histone deposition, although the nucleosome 
spacing of the resulting chromatin is disturbed (Demeret et al. 2002; MacCallum et al.
2002). However, protein-free DNA and sperm chromatin, two common templates for 
remodeling and replication in egg extracts, are very different substrates from the native 
chromatin described in the previous experiments (Collins et al. 2002), so it is difficult to 
compare the results directly.
The WICH complex, found in both Xenopus and mammals, consists of ISWI 
(SNF2H) and WSTF, and has been linked both to replication and transcription. In mouse 
cells, WICH is localized to pericentric heterochromatin during replication (Bozhenok et 
al. 2002), in the same way that ACF1 and SNF2H are localized in human cells (Collins et 
al. 2002). W STF is related to ACF1 (also known as WCRF180, W STF-related chromatin 
remodeling factor) (Bochar et al. 2000), but the functional differences between ACF and 
WICH complexes are not clear. In Xenopus, WICH also binds stably to mitotic 
chromosomes, clearly distinguishing it from the S-phase chromatin binding of ACF 
(Bozhenok et al. 2002). In addition, W STF itself may also occur in a complex with 
SW I/SNF in human cells (Kitagawa et al. 2003).
A potential yeast homolog of CHRAC has recently been described (Iida and Araki 
2004). This complex is related to the previously characterized Isw2 complex, which
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consists of Isw2p and Itc lp  (Tsukiyama et al. 1999), but contains two additional small 
subunits: Dpb4p, a histone-fold motif-containing subunit of the replicative DNA 
polymerase s; and D lslp , which is related to the histone-fold partner of Dpb4p, Dpb3p. 
Dpb4p is the yeast homolog of the CHRAC-17 subunit (which is also a component of 
human Pol e ) .  yCHRAC has also been shown to have functional links to replication. Pol 
e  and yCHRAC have opposing effects on epigenetic silencing at the telomere, with Pol e 
promoting silencing and yCHRAC promoting expression of subtelomeric genes. This 
suggests that the interplay between Pol e and yCHRAC (perhaps mediated by their 
common subunit, Dpb4p) controls the maintenance or resetting of the epigenetic state of 
the telomeres during replication.
Transcriptional regulation: NURF , NoRC, Isw l, lsw2
The first ATP-dependent remodeler to be characterized, yeast SWI/SNF, was 
identified genetically as a positive regulator of transcription (Hirschhorn et al. 1992; 
Peterson and Herskowitz 1992; Laurent et al. 1993; Peterson et al. 1994). In vitro, all of 
the SW I2/SNF2 superfamily-containing complexes are able to make DNA in chromatin 
accessible to site specific binding factors, such as transcription factors or restriction 
enzymes (Imbalzano et al. 1994; Kwon et al. 1994; Logie and Peterson 1997; Boyer et al. 
2000; Fan et al. 2003). For years, this work seemed to foster the belief that all chromatin 
remodelers would turn out to be transcriptional activators. However, some early work 
clearly indicated that chromatin remodelers could also be involved in repression. The 
human SW I2/SNF2 family members hbrm and Brgl have been shown to work as 
corepressors with RB (retinablasoma) (Trouche et al. 1997; Murphy et al. 1999), and the
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appearance of the SWI2/SNF2 homolog Mi-2 in complexes with histone deacetylases 
raised the idea that remodeling might also be involved in transcriptional repression 
(Zhang et al. 1998). Since then it has become clear that chromatin remodeling can result 
in activation or repression of transcription in vivo. This is discussed below in detail for 
ISWI.
ISWI family complexes appear to both activate and repress transcription. The 
first role for an ISWI complex in transcription came from work in the Wu laboratory on 
the NURF complex (Tsukiyama et al. 1994; Tsukiyama et al. 1995; Tsukiyama and Wu 
1995; Mizuguchi et al. 1997). In addition to ISWI, NURF contains three other protein 
subunits: NURF55, NURF38 (an inorganic pyrophosphatase) and a large NURF301 
subunit (Gdula et al. 1998; Martinez-Balbas et al. 1998). Work in vivo has shown that 
nurf301 and iswi mutations result in impaired transcription of heat shock genes (hsp70 
and hsp26) and homeotic genes (ubx and en) (Deuring et al. 2000; Badenhorst et al.
2002).
The recently isolated human NURF complex, the only known SNF2L-based 
complex, is also involved in transcriptional activation. In fact, depletion of SNF2L using 
RNAi results in the reduced expression of the human engrailed  genes en-1 and en-2, 
homologs of the Drosophila en gene that requires NURF for its expression (Barak et al.
2003).
In contrast, other ISWI complexes are primarily involved in transcriptional 
repression. The NoRC complex, the mammalian nucleolar remodeler, is composed of 
SNF2H and TIP5, a protein originally identified as a partner of the RNA Pol I
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termination factor TTF-1 (Strohner et al. 2001). TTF-1 is also somewhat related to 
WSTF and A cfl/W CRF180, providing a link between multiple ISWI complexes. NoRC 
has since been shown to be involved in repression of Pol I transcription, through the 
recruitment of the SIN3/HDAC1 corepressor complex to the rDNA promoter (Zhou et al. 
2002).
In yeast, Isw i a, Isw lb, Isw2 have all been implicated in transcriptional 
repression. The Isw2 complex is recruited by the general repressor Ume6p, and represses 
early meiotic genes (Goldmark et al. 2000), /M 9/(K ent et al. 2001), a-cell specific genes 
in a-cells (Ruiz et al. 2003), and a variety of metabolic, stress-responsive, and other 
genes (Fazzio et al. 2001). Likewise, deletion of components of the Iswi complexes 
suggests that Iswi plays a primary role in transcriptional repression, measured by whole 
genome expression analysis (Vary et al. 2003).
Other studies of the Iswi complexes have revealed that they play a role in a 
different aspect of transcriptional regulation: elongation and termination (Alen et al.
2002; Morillon et al. 2003). Morillon et al. (2003) proposed that Isw lp  sequentially 
regulates each stage of the transcription cycle, linking events at the 5' and 3' end of the 
transcription unit and controlling the amount of RNAPII entering productive elongation. 
In fact, these studies appear to have separated the roles of Isw i a and Isw lb: Iswi a 
(Isw lp  + Ioc3p) acts as a repressor and prevents transcription initiation, while Isw lb  
(Isw lp , Ioc2p, Ioc4p) appears to control elongation, coordinating Pol II CTD 
phosphorylation with events involved in RNA 3 ’ end formation, and may also promote 
release of Pol II during terminantion (Morillon et al. 2003). The ability of Isw Ito regulate
transcription of some genes is linked to Setlp-dependent methylation of histone H3 in 
vivo (Santos-Rosa et al. 2003).
Higher-order chromosome structure: ISWI/cohesin, ISWI-?
Mitotic (or meiotic) chromatin, the most highly condensed state of eukaryotic 
DNA, represents an extra challenge for any factors that require access to the DNA. Some 
genes in yeast appear to require more remodeling to be expressed during mitosis than 
during other stages of the cell cycle (Krebs et al. 2000). Chromosomes also exhibit 
unique behaviors during mitosis and meiosis; one of the most striking being the cohesion 
of sister chromatids before anaphase, and their abrupt release at the metaphase-to- 
anaphase transition (Haering and Nasmyth 2003; Hagstrom and Meyer 2003; Morrison et 
al. 2003). It should come as no surprise that unique structures of mitotic and meiotic 
chromosomes also depend on chromatin remodelers.
In the case of sister chromatid cohesion, cohesin loading appears to require a 
complex of complexes (Hakimi et al. 2002). Human SNF2H is associated not only with 
the core cohesin complex (hRAD21, SMC1, SMC3 and SA1/SA2), but also with the 
NuRD complex, which contains Mi-2 (another SWI2/SNF2 family ATPase), the methyl- 
DNA-binding proteins MBD2 and -3, HDAC1 and -2, the metastasis-associated proteins 
MTA1 and -2, and the Rb-associated proteins RbAp46 and -48 (Feng and Zhang 2003). 
These associations, identified using extensive biochemical fraction and affinity 
chromatography, are also reflected in vivo in chromatin immunoprecipitation (ChIP) 
experiments that show colocalization of SNF2H, NuRD and cohesion at multiple Alu 
sequences. This colocalization also correlates with histone H3K4 methylation and H3/H4
acetylation (which implies that there is little active deacetylation occurring from the 
NuRD complex in this context). Importantly, the association between cohesin and 
chromatin requires a catalytically active SNF2H, suggesting that the remodeling function 
of SNF2H is critical for cohesin loading.
ISWI complexes in other species have not yet been associated with sister 
chromatid cohesion, but they have been implicated in similarly large-scale chromatin 
events. ISW I and NURF30I mutations in Drosophila have dramatic and global effects on 
the structure of the male X chromosome in polytene chromosomes (Deuring et al. 2000; 
Badenhorst et al. 2002). The X chromosomes are significantly shorter and broader in 
males, whereas the autosomes in both males and females tend to be thinner than normal 
in the ISW I mutants. Polytene chromosomes are generated by multiple cycles of 
endoreplication (replication without division). The observed effects could be due to a 
replication or assembly defect in these mutants, though clearly this effect differs for the 
male X and must therefore also be linked to dosage-compensation mechanisms.
ISWI can play a role in global chromosome structure in Xenopus as well.
Although ISWI is dispensable for the decondensation and replication of sperm chromatin 
(Demeret et al. 2002; MacCallum et al. 2002), remodeling of somatic nuclei in egg 
cytoplasm is critically dependent on ISWI (Kikyo et al. 2000). The remodeling of the 
somatic nuclei was measured by monitoring the energy-dependent loss of TBP (TATA- 
binding protein) from the incoming chromosomes. Although the normal in vivo function 
of this activity is not clear (it is clearly not analogous to sperm chromatin remodeling), it
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has important implications for the mechanism of “epigenetic resetting” in somatic cell 
cloning and dedifferentiation (Wade and Kikyo 2002).
Role o f  ISW I in whole organisms
Unlike the specific functions of ISWI complexes discussed above, the role of 
ISWI in multicellular organisms as a whole can be summed up succinctly: it is essential. 
(In contrast, yeast cells lacking the ISW I and ISWI2 genes are viable, raising the question 
of whether another complex substitutes for an essential function performed by ISWI in 
other species, or whether ISWI performs a function only essential to multicellular 
organisms.) Null mutations in ISW I or NURF301 are lethal in the late larval/early pupal 
stage of development, and dominant-negative ISW I mutants result in loss of viability in 
each cell type they are expressed in (Deuring et al. 2000; Badenhorst et al. 2002). Snf2h- 
/- mice die during the peri-implantation stage, and Snf2h also appears critical for 
individual cell viability (Stopka and Skoultchi 2003). Xenopus also require ISWI for 
survival; ISW I-deficient Xenopus embryos die during late neurulation (Dirscherl and 
Krebs, unpublished data). In most of these experiments (with the exception of the NURF 
studies in Drosophila), the common subunit ISWI was targeted, so it remains to be seen 
which specific ISWI complexes are essential for cell viability and (or) development.
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Chapter 3 
Neural and eye-specific defects associated with loss of the Imitation Switch (ISWI) chromatin remodeler in Xenopus laevis 
Introduction
The embryonic development of multicellular organisms is a complex and orderly 
process that depends on precise regulation of spatial and temporal patterns of gene 
expression. Cell specification and differentiation require that some gene loci become 
constitutively or inducibly expressed, while other loci become actively silenced. Cell 
type-specific patterns of expression and repression must often be maintained through 
subsequent rounds of cell division to preserve cell-lineage fidelity. Transcription 
activation and repression occurs in the context of chromatin, a complex of DNA and 
proteins that compacts DNA into the eukaryotic nucleus. The repeating structural unit of 
chromatin is the nucleosome, which is composed of 147 base pairs of DNA wrapped 
around an octamer of histone proteins. The compaction of DNA into chromatin, which 
functions to keep the genome organized within the boundaries of the cell nucleus, also 
suppresses gene activity. An essential step in gene activation includes the remodeling of 
nucleosomes at target promoters and enhancers, which facilitates binding of transcription 
factors. A combination of chromatin remodeling enzymes and histone modifying 
enzymes establish a steady level of transcriptional control in all eukaryotes 
(Khorasanizadeh 2004).
The ATP-dependent chromatin remodeling complexes use the energy of ATP 
hydrolysis to locally disrupt or alter the association of histones with DNA, or to slide
nucleosomes along the DNA. ATP-dependent chromatin remodeling complexes can 
facilitate gene activation or repression by helping transcription factors or histone 
modifying enzymes gain access to their targets in chromatin. All of the ATP-dependent 
chromatin remodeling complexes contain a catalytic ATPase subunit that belongs to the 
SW I2/SNF2 superfamily of proteins. These ATPases have been classified into several 
subfamilies, the largest of which are the SWI2/SNF2 group and the Imitation Switch 
(ISWI) group (Eisen et al. 1995).
Multiple ISWI-containing complexes have been identified in yeast, Drosophila, 
Xenopus, and mammals. ISWI complexes are involved in multiple nuclear functions, 
including transcriptional activation and repression, replication, and chromatin assembly 
(Dirscherl and Krebs 2004). Null and dominant negative ISW I mutants have 
demonstrated that ISWI is essential for cell viability and required for gene expression 
during development in Drosophila (Deuring et al. 2000), including expression of 
homeotic genes (Badenhorst 2002).
Homologs of ISW I have been identified in human and mouse (Snf2h and Snf2l) 
(Okabe et al. 1992; Aihara 1998; Lazzaro and Picketts 2001). Both ISW I homologs are 
expressed during development of the nervous system in mice, but they exhibit differential 
expression patterns (Lazzaro and Picketts 2001). Snf2h is transiently expressed in 
proliferating cell populations during embryogenesis and early postnatal development, 
while Snf2l expression is upregulated in terminally differentiated neurons after birth and 
persists in adult animals. A human complex containing SNF2L is involved in the 
induction of neurite outgrowth in tissue culture (Barak et al. 2003). Intriguingly, the Snf2l
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including transcriptional activation and repression, replication, and chromatin assembly 
(Dirscherl and Krebs 2004). Null and dominant negative ISW I mutants have 
demonstrated that ISWI is essential for cell viability and required for gene expression 
during development in Drosophila (Deuring et al. 2000), including expression of 
homeotic genes (Badenhorst 2002).
Homologs of ISW I have been identified in human and mouse (Snf2h and Snf2l) 
(Okabe et al. 1992; Aihara 1998; Lazzaro and Picketts 2001). Both ISW I homologs are 
expressed during development of the nervous system in mice, but they exhibit differential 
expression patterns (Lazzaro and Picketts 2001). Snf2h is transiently expressed in 
proliferating cell populations during embryogenesis and early postnatal development, 
while Snf2l expression is upregulated in terminally differentiated neurons after birth and 
persists in adult animals. A human complex containing SNF2L is involved in the 
induction of neurite outgrowth in tissue culture (Barak et al. 2003). Intriguingly, the Snf2l
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Fgene is localized to a region of the X chromosome associated with multiple X-linked 
mental retardation (XLMR) disorders (Lazzaro and Picketts 2001).
Four ISWI-containing complexes have been identified in Xenopus through 
biochemical fractionation of Xenopus oocytes (Guschin et al. 2000), three of which are 
homologs of ISWI complexes in other species. The most abundant ISWI complex in 
oocytes is xACF (ATP-dependent chromatin assembly factor). Xenopus also contains 
CHRAC (chromatin accessibility complex) and WICH (W STF-ISWI chromatin 
remodeling complex) (Bozhenok et al. 2002). The subunit composition of the fourth 
ISWI complex has not been elucidated. Comparison of the remodeling activity of 
Xenopus ISWI complexes in vitro fails to reveal significant qualitative or quantitative 
differences (Guschin et al. 2000). The subunits unique to each ISWI complex could 
determine the specific nuclear function for each complex (chromatin assembly vs. 
transcriptional regulation vs. replication). Unquestionably, the developmental program of 
Xenopus, with an early period of rapid nuclear divisions, places a special burden on the 
machinery for chromatin assembly and remodeling. The multiple ISWI complexes 
described here may reflect those specialized demands.
A number of SWI2/SNF2-family ATP-dependent chromatin remodelers have 
been linked to developmental processes. There are several developmental disorders in 
humans associated with loss of function of chromatin remodelers. These include: ATRX 
mutations and mental retardation (Picketts et al. 1996) SMARCAL1 and Schimke 
immunoosseous dysplasia (Boerkoel et al. 2002), CSB and Cockayne syndrome (Citterio 
et al. 2000) and SNF2H and Williams syndrome (Bochar et al. 2000). Williams
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syndrome is a developmental disorder linked to the ISW I-containing complex WICH, 
which contains the Williams Syndrome Transcription Factor (W STF) and therefore 
suggests a possible transcriptional role for this complex. WICH also appears to have a 
direct role in the replication of heterochromatin (Bozhenok et al. 2002).
I wished to understand the functional diversity of ISWI complexes by defining the 
functions of different ISWI complexes in the whole organism. I began by analyzing the 
role of the one subunit common to all the ISWI complexes, ISWI itself. In this study I 
used Xenopus laevis to examine the expression pattern and regulatory effects of ISW I 
mRNA in the developing vertebrate embryo. In situ hybridization reveals ISW I mRNA to 
be localized almost exclusively in neural tissue. I inhibited ISWI function in early 
embryos by three methods: microinjection of antisense mRNA or microinjection of 
morpholino oligonucleotides to inhibit the translation of endogenous ISW I mRNA, and 
microinjection of mRNA encoding a dominant negative mutant of ISWI. I have shown 
that ISWI knockdowns result in gastrulation defects, incomplete closure of the neural 
tube, delayed development, misexpression of neural-specific genes, eye 
malformationsand the formation of cataracts. These results reveal an essential role for 
ISWI both in early development and in later stages of neural development.
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Materials and Methods
RNA fo r  Microinjection:
A 3500bp ISW I cDNA cloned into pBSKS was kindly provided by Dr. Paul Wade 
(Emory University). This ISWI clone was digested with Kpnl and PstI and a 343bp 
fragment corresponding to nucleotides 2143-2486 was isolated and inserted into pBSSK 
to create a plasmid capable of transcribing an antisense RNA with the T3 promoter. 
Transcripts were synthesized using Megascript ™ (Ambion, Austin, TX). For in situ 
hybridization the same procedure was used except a digoxigenin-labeled UTP was 
incorporated. A plasmid capable of transcribing a full length GFP  mRNA was provided 
by Dr. Richard Harland (UC Berkeley), and was used as an RNA injection control in 
these experiments. mRNA was transcribed using Megascript™ (Ambion, Austin, TX) 
and tailed using a Poly (A) Tailing Kit™ (Ambion, Austin, TX).
Morpholinos:
A 25-mer antisense morpholino (5'-GCTTTCCGCAGACATGACTCGCAGC-3') 
was designed against the 5 ’ UTR of Xenopus ISW I immediately adjacent to the 
translation start (Gene Tools, LLC, Philomath, OR). Per Gene Tools recommendations, 
morpholinos were resuspended at ImM and injected into embryos to give final 
concentrations in the range of 1-10 ^M  (10 pM  H 80 ng total injected morpholino). A 
sample of morpholino was also lyophilized and resuspended at 2 mM high concentration 
injections. For a control, I use a standard control 25-mer (5’-CCTCTTACCTCAGTTA 
CAATTTAT-3’) available from Gene Tools, LLC (Philomath, OR). This oligo has no 
target (except in reticulocytes from thallasemic humans with a specific a-globin
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mutation) and is a commonly used negative control in antisense morpholino experiments. 
A 25-mer antisense morpholino (5 ’-GGCGT AGCCAT CT A AT GTTCT GG AG-3 ’) was 
also designed against xbrm  (Xenopus brahma).
Mutagenesis:
A dominant negative ISW I mutant of the Wade ISWI plasmid was created using 
the mutagenic primers 5 ’ GGCT G ATG A A AT GGGTCT AGG AGCG ACTTT GCAG ACC- 
3 ’ and 5 ’GGTCTGCAAAGTCGCTCCTAGACCCATTTCATCAGCC-3\ converting 
the lysine at position 612 to an alanine. Mutagenesis was performed using 
Quickchange™ (Sigma, St. Louis, MO).
Microinjection:
Adult Xenopus were purchased from Xenopus Express (Plant City, FL). Embryos 
were obtained by in vitro fertilization and microinjection into the one cell stage was 
carried out by standard methods (Sive et al. 2000). Antisense RNA was injected at 
concentrations of 200, 400 and 1000 pg/nl. Morpholinos were injected at 500 uM, 1 mM 
and 2 mM (equivalent to 4, 8, 16 ng/nl), as suggested by the manufacturer. GFP was 
injected at 1000 pg/nl. 10 nl was injected into each embryo. Embryos were incubated at 
16°C for 24-48 hours and staged according to Nieuwkoop and Faber (Nieuwkoop and 
Faber 1967). Extensive GFP staining was observed throughout embryos in which GFP 
mRNA was injected, indicating that diffusion of injected material from the injection site 
was not a problem.
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Protein isolation and immunoblotting:
Protein was collected at stage 12/13 according to M erzdorf (M erzdorf and 
Goodenough 1997). A final concentration of lpiM PMSF was added to the protein 
isolation buffer, and DIFP, chymostatin and Trasylol were omitted from this buffer. 
Samples were then run on an SDS-page gel and transferred using standard methods 
(Sambrook and Gething 1989). Dr. Paul Wade generously provided ISWI antibody. E- 
Cadherin antibody (5D3) was obtained through the Developmental Studies Hybridoma 
Bank at the University of Iowa (Iowa City, IA).
Whole mount in situ hybridization:
Albino embryos were collected after in vitro fertilization and fixed in MEMFA 
according to Sive et. al (2000) (Sive et al. 2000). (Embryos were then rehydrated and 
assayed according to Sive et al. (2000) with the following changes: RNAse step was 
omitted, and a second preantibody incubation step with 2% BMB blocking reagent and 
20% sheep serum in MAB for 1 hour at room temperature was added. AP buffer minus 2 
mM levamisol was used as detection buffer. NBT/BCIP was used for the detection 
method. Negative controls for in situs were performed using ISWI sense strands; 
examples are shown in Appendix B.
Histology:
Fixed embryos were dehydrated though a graded series of ethanol and xylene, 
embedded in Paraplast Plus (Oxford Labware, St Louis, MO) and serial sectioned at a 
thickness of 7pim. Sections were collected on albumin-subbed slides (Mayer's fixative, 
(Humason 1972)). Sections were stained using Ehrlich's hematoxylin and counterstained
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in Eosin following the protocols of Humason (1972). Coverslips were applied using 
Permount (Fisher Scientific, Pittsburgh, PA). Color images were captured using a Spot 
digital camera (Diagnostic Instruments, Inc. Sterling Heights, MI).
R T-PC R:
Total RNA was isolated using RNAWIZ™ (Ambion). One step real-time RTPCR 
was performed using Lightcycler™ reagents and the Cepheid Smartcycler (real time 
PCR). Reactions contained 1 fig total RNA and 2.5 pmol of primer, and were subjected to 
25 cycles. RNA concentration range was confirmed with a 10 fold dilution series. 
Annealing temperatures were optimized for each primer set. Products were detected using 
Cyber Green during the real-time PCR reaction and/or running the final products on a 1- 
2% agarose gel. Data was quantified on 1-2% agarose gels using imaging software 
(Kodak ID Image Analysis Software version 3.5). PCRs were performed a minimum of 
three times with samples from independent injection experiments. Primers were obtained 
through Sigma Genosys (St. Louis, MO). Primer sequences for Hoxb9, MyoDb, E F la , 
and NCAM  were obtained through Xenbase (www.xenbase.org). X m eislb  was previously 
described (Maeda et al. 2001). Sequences for other primers are as follows:
B M P 4 : 5-'CCATGCCAGCCTCATACC-3' + 5'-GCTGGTCGGTCTCTCAGG-3'
Shh; 5 '-GGTTCGACTGGGTCTATTACG-3' + 5'-CGATGAACATGAGGAAGTCG-3' 
Slug: 5’-GGACTTAACTCCTGCAGG-3' + 5 '-GGATCGTTGCTGGATTGTCTAGG-31 
Sox9: 5 ’-GGAGACTTCTGAATGAGGG-3' + 5 ’-GCTGGATATCTGTCTTGGG-3'
Pax6: 5’- CCGAGAAATGTCGCAGGG-3' + 5'- GGAATTACACAGTCCCTGGG-3’
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Chromatin Immunoprecipitation:
Groups of 100 embryos were fixed in MEMFA (0.1 M Mops pH 7.5, 2 mM 
EGTA, 1 mM M gS04, 3.7% formaldehyde) for 30 min, rinsed briefly and homogenized 
in lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris-HCL pH 8.1, 1 ^1/ml Leupeptin, 1 
mM PMSF, 1 //1/ml Pepstatin). Homogenized embryos were passed through a 20 gauge 
needle (20 passes). Chromatin was sonicated to yield DNA fragments between 200 and 
500bp. Debris was removed by centrifugation for 10 min at 5,000 rpm at 4°C, 
supernatant was collected and spun again. DNA was quantified by measuring the 
absorption at 260 nm. Each sample was then diluted to 0.1 uglpd in lysis buffer. 
Subsequent steps were performed as described (Strahl-Bolsinger et al. 1997; Kuo and 
Allis 1998). Input and immunoprecipitated material was detected via slot blot.
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Results
Xenopus ISWI is expressed in neural tissues
Two nearly identical ISW I genes have been isolated from Xenopus, ISW I I 
(Demeret et al. 2002) and ISW I 2 (Guschin et al. 2000), which differ only by a 9 amino 
acid stretch that is not present in ISWI 2 (amino acids 179-188 of ISW I 1). Probes and 
antibodies that detect both ISW ls reveal that ISWI is maternally deposited in the oocyte, 
and is also expressed continuously throughout embryonic development (Demeret et al.
2002), though localization of expression was not addressed in that study.
As a first step in determining the function of ISWI in Xenopus, I performed in situ 
hybridization in whole-mount embryos to determine the patterns of expression of ISW I in 
different developmental stages. The in situ probe recognizes both ISW I 1 and ISW I 2. The 
pattern of ISWI staining in selected stages (stages 18 and 40) is shown in figure 1A-J (see 
also figure 2D-F). My results indicate that xenopus ISW I mRNA is localized to neural 
tissues throughout development. Specifically, ISW I is detected in the neural folds, in the 
cranial crest/brachial arches, in the otic vesicle, and to some extent in the migrating 
hypaxial muscles in early embryos. In later stages, ISW I is expressed throughout the brain 
and spinal cord. ISW I also exhibits strong eye staining in all stages. These results were 
surprisingly analogous to the recent findings that xBaf57 (a homolog of a subunit of 
mammalian and Drosophila SWI/SNF complexes) increases the expression of neural 
markers in ectoderm explants and is expressed in mesoderm during gastrulation and the 
nervous system during the neurula and tailbud stages of the Xenopus embryo
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Figure 3.1 Whole mount in situ hybridization of Xenopus embryos with a 300bp ISWI digoxigenen-labeled 
probe. A-J: Corresponding dorsal and left lateral views of stage 18 (A-B), 24 (C-D), 26 (E-F), 28 (G-H) 
and 33 (1-J) embryos showing expression of ISWI in regions of the neural tube, brain, and optic vesicles. 
All embryos are oriented with the anterior end towards the left side of the figure, lnt: lateral neural tube; nt: 
neural tube; ov: optic vesicle; ot: otic vesicle; oc: optic cup; br: brain, ba: brachial arches; hm: hypaxial 
muscles. Scale bar equals 1 mm. For controls see appendix B.
control antisense control anti-ISW I 
ISW I m RNA morpholino morpholino
Figure 3.2 Xenopus laevis embryos injected with antisense ISWI RNA or ant\-ISWI morpholino. A-C: 
Embryos photographed when control-injected embryos reached approximately stage 20-22. Embryos were 
injected with either 8 ng/nl control morpholino (A), 0.4 ng/nl of antisense ISWI RNA (B; representative of 
phenotype observed for injection of 0.2 and 1 ng/nl as well) or 8 ng/nl anti-/5W/ morpholino (C; also 
representative of other of 4 ng/nl and 16 ng/nl morpholino inections). D-F: Whole mount in situ 
hybridization of stage 12 (D), 13 (E) and 14 (F) embryos with the ISWI probe described in Figure 1, 
showing early differential expression of ISWI. These are dorsal views with the anterior to the left side of 
the figure. Black dashes indicate the midline for each embryo. G-H: Embryos injected with 8 ng/nl of 
either control morpholino (G) or anti-/SWY morpholino (H). The embryo in H represents one of the very 
few embryos to survive the initial gastrulation defect at high morpholino concentrations. Scale bar: 1 mm. 
I: Western blot showing reduced levels of ISWI protein in embryos injected with 1 ng/nl of ISWI antisense 
RNA (left), or 8 ng/nl anti-ISWI moropholino (right), compared to control embryos injected with nanopure 
water or control morpholino (8 ng/nl), respectively. Antibody against E-cadherin (E-cad) is used as a 
loading control.
(Domingos et al. 2002). The fact that two different remodeling complexes are involved in 
nervous system development is very intriguing. A recent comprehensive survey of 
expression of SWI2/SNF2 family members in tailbud-stage embryos revealed that in fact 
all SW I2/SNF2 family members are expressed to varying extents in the brain, but exhibit 
greatly varying expression patterns in other tissues, including other neural tissues (Linder 
et al. 2004). Note that the in situs described by Linder et al and in this work do not 
distinguish the localization of the two different ISWI transcripts. 
xISW I expression is required fo r  normal gastrulation and neural development
To determine the function of ISWI in Xenopus development, either a 300bp 
antisense ISW I RNA or an anti-ISWI morpholino was injected into fertilized eggs to 
inhibit translation of endogenous /SWYmRNA. Eggs were injected with 2, 4 or 10 ng of 
RNA or 40, 80 or 160 ng of morpholino. While some studies have obtained results with 
lower concentrations of morpholinos, this concentration range was chosen according to 
the manufacturer’s recommendations and is consistent with other published studies 
(Audic et al. 2001). For controls, eggs were injected with 10 nl of water, 10 ng of GFP  
mRNA, or 40, 80 or 160 ng of a control morpholino (see tables I and II). Embryos were 
allowed to develop at 16°C. Representative injected embryos are shown in figure 2A-C 
and G-H. At approximately 30 hours post-fertilization, when control embryos had 
reached stages 18-22 (figure 2A), an interesting phenotype began to emerge. Anti-/SW7 
injected embryos showed widespread failure of gastrulation and disruption of neural tube
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Table 3.1 Neural phenotypes in injected embryos.
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Concentration (x 10 nl injected per embryo) Total # of embryos
# of embryos with neural defects3
% of embryos with neural defectsUninjected 1252 31 2%Water 998 89 9%GFP  mRNA 1 ng/nl 1117 167 15%Control MO 4 ng/nl (0.5 mM) 573 81 14%8 ng/nl (1 mM) 538 21 4%16 ng/nl (2 mM) 484 61 13%Anti-/SW7 mRNA 0.2 ng/nl 933 434 47%0.4 ng/nl 599 452 75%1 ng/nl 500 442 88%Anti-/5VV7 MO 4 ng/nl (0.5 mM) 689 228 33%8 ng/nl (1 mM) 575 488 85%16 ng/nl (2 mM) 284 253 89%DN-AS’VVY mRNA 1 ng/nl 631 507 80%D N-ISW I mRNA +WT ISW I mRNA 1 ng/nl + 0.5 ng/nl 148 63 43%D N-ISW I mRNA +WT ISW I mRNA 1 ng/nl + 1 ng/nl 229 77 33%includes failure of gastrulation, neural tube closure, brain, eye and spinal deformities
Table 3.2 Cataract formation in injected embryos.
Concentration (x 10 nl injected per embryo) T otal # of embryos # of embryos with cataracts % of embryos with cataractsGFP  mRNA 1 ng/nl 97 0 0Control MO 8 ng/nl (1 mM) 273 0 0Anti-ISW I MO 8 ng/nl (1 mM) 150 133 89%DN-/SW / mRNA 1 ng/nl 109 83 76%
closure (figure 2B, antisense ISW I RNA-injected embryo; figure 2C, anti-ISWI 
morpholinoinjected embryo). At the highest doses of antisense or morpholino, close to 
90% of the embryos exhibited these defects, compared to only 13-15% gastrulation 
failure in the equivalent control injections (table 1). Injection of 40 ng of the control 
morpholino does not affect development (e.g. figure 2G, embryo injected with control 
morpholino). Although it was already known that ISWI is present in the oocyte and 
throughout early development (Demeret et al. 2002), the early defects in gastrulation and 
neurulation led us to wonder whether ISW I is already exhibiting differential expression at 
these early stages. I therefore performed in situ hybridizations in embryos between stages 
10 and 14. Representative in situs are shown in figure 2D-F. ISWI stains diffusely 
throughout the dorsal half of stage 10 embryos (not shown), but begins to localize to the 
anterior end by stage 12 (figure 2D), and shows clear neural plate and neural fold staining 
in stages 13/14 (figure 2E-F). This confirms that ISWI expression is rapidly localized to 
presumptive neural tissue early in development, consistent with the early critical role 
revealed in the antisense/morpholino injections.
A percentage of antisense- or morpholino-injected embryos survive the early 
defects and go on to reveal later developmental abnormalities. The example shown in 
figure 2E illustrates an anti-ISWI morpholino-injected embryo (40 ng) at approximately 
stage 40 (compare to the control morpholino-injected embryo in panel G). This embryo 
exhibits spinal deformities and dramatically reduced brain and eye development. At 
lower doses of ISWI inhibition (e.g. 40 ng of anti-/SW / morpholino), more embryos
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survive the early gastrulation defects and go on to exhibit a spectrum of later neural 
defects, including severe eye defects, described below.
To confirm that ISWI translation was specifically inhibited in these embryos, I 
isolated total protein from stage 12 embryos that were injected with either 1 ng/nl 
antisense ISW I RNA or 8 ng/nl anti-ZSW/ morpholino. Total protein was also isolated 
from water or control-morpholino embryos at the same stage. The protein was run on an 
SDS-page gel and screened by western blot for ISWI protein, using an anti-ISWI 
antibody generously provided by Dr. Paul Wade (Emory University, Atlanta, GA). 
Processed ISWI protein runs at about 137 kDA. Western analysis reveals that ISWI 
protein levels are reduced but not eliminated in the antisense-injected embryos (figure 2F, 
left). In contrast, ISWI was completely undetectable in the morpholino-injected embryos 
(figure 2F, right). For loading controls, I used both Coomassie staining (not shown) and 
detection of E-cadherin protein, which was detected at similar levels in all samples. This 
clearly indicates that both the antisense ISW I RNA and the anti-/SVV7 morpholino are 
successfully reducing or preventing the translation of endogenous ISW I mRNA. The 
consistency between the phenotypes observed for both antisense RNA and morpholino 
methods strongly suggest the defects are due to the specific loss of ISWI (and not the 
result of non-specific toxicity of the anti -ISWI morpholino), and the western data 
supports this conclusion. A third method of ISWI inhibition using a dominant negative 
approach yields the same results (figure 4). In addition, I have also designed a 
morpholino that inhibits expression of xbrm  (Xenopus brahma), a SW I2/SNF2-family 
member related to ISWI. This morpholino, injected at the same concentrations as the anti-
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ISW I morpholino, does not result in gastrulation or neural defects but rather in later 
developmental defects unrelated to the defects observed in ISWI-deficient embryos (E. E. 
Brown, S.S.D. and J.E.K., unpublished results). 
x IS W I is required fo r  norm al expression o f  neural genes
Formation of the central nervous system (CNS) in vertebrates is initiated during 
gastrulation and depends on the inductive interaction of the ectoderm and the adjacent 
dorsal mesoderm. The CNS is characterized by overt anteroposterior (AP) and 
dorsoventral patterning (Doniach 1993; Mathis 2002). Nieuwkoop has described the 
predominant concept of how AP patterning is formed in a two-step model (Nieuwkoop 
1955). The first step, “activation,” is thought to specify anterior neuroectodermal 
structures, such as the forebrain. The second step is “transformation” where anterior 
neural tissue is respecified to more posterior fates such as midbrain, hindbrain and spinal 
cord. A number of genes have been identified whose regulation is critical in this process 
(Weinstein and Hemmati-Brivanlou 1999; Knecht and Bronner-Fraser 2002).Many ATP- 
dependent chromatin remodelers have been shown to act by regulating transcription, both 
positively and negatively. To determine whether ISWI controls expression of genes 
involved in neural development, I initiated a search for specific gene targets of ISWI. I 
tested whether expression of a number of known neural marker genes was affected in the 
injected embryos. Total RNA was purified from the antisense- or morpholino-injected 
embryos and subjected to RT-PCR using primers against a variety of neural markers 
expressed at different times and positions in neural development. These include BMP4
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Figure 3.3 RT-PCR of tissue-specific genes in anti-/5W/ morpholino-injected embryos. Total RNA was 
collected from embryos at the specified stages and real-time RT-PCR was performed with specific neural 
gene primers. A. Products of RT-PCR reactions. E F la  was tested at stages 10, 12, 13, 15, 18 and 20. The 
stage 13 data is shown and is representative of all stages tested. Other genes shown were analyzed at the 
following stages: BMP4, stage 10/11; Sox9 and Shh, stage 13; Pax6 and MyoD, stage 15/16; HoxB9, stage 
18/20. B. Quantitative data from real-time RT-PCR, showing the level of expression (as percentages) of 
each gene compared to the levels in control-injected embryos. Each bar represents the average from a 
minimum of three injection experiments. Standard errors are shown. C. Representative slot blots of 
chromatin immunoprecipitations with anti-ISWI antibody. Chromatin was extracted from stage 12/13 
embryos; comparable results were obtained with later stages. Left panel was probed for BMP4, right panel 
was probed for MYOD. D. Average enrichment of ISWI at BMP4 in uninjected and anti-ISWI MO-injected 
embryos (stage 12/13). Standard errors are shown.
(bone morphogenic protein4; an inhibitor of neural tissue formation that is expressed 
throughout the late blastula and is down-regulated in neural tissue at approximately stage 
10), Xmeis (a pre-pattern neural crest marker that is expressed with the down-regulation 
of BMP4), Shh (sonic hedgehog; an early notochord marker expressed at gastrulation), 
Pax6 (a key regulator of eye development expressed continuously from stage 14), NCAM  
(neural cell adhesion molecule; expressed in most neural tissue at the start of 
gastrulation), Sox9 (a progenitor of cranial neural crest formation, expressed at the start 
of gastrulation and persists through early development), Slug (a neural crest and system 
marker is expressed at early to mid neurula stage). As controls, I also detected the lateral 
plate marker expressed at the start of neurulation), and HoxB9 (a central nervous system 
marker is expressed at early to mid neurula stage). As controls, I also detected the 
expression of the muscle specific MyoD  gene and the gene encoding the ubiquitously 
expressed translation protein E F la . We performed real-time RT-PCR on samples from 
both antisense RNA- and anti-/SW / morpholino-injected embryos. The results were the 
same for both; data for the morpholino injections are shown in figure 3. Figure 3A shows 
representative PCR products from the RT-PCR reactions. The average level of expression 
for each gene in the ISW I knockdown embryos is expressed as a percentage of the level 
of expression in control-injected embryos (figure 3B). Each bar represents the data from a 
minimum of three separate injection experiments, and standard errors are shown. Xmeis, 
Shh, Pax6, NCAM, Sox9, Slug and HoxB9 all show a decrease in expression compared to 
embryos injected with water, GFP or control morpholino (figure 3 and data not shown), 
suggesting that ISWI is acting at a very early step in this developmental cascade, which is
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consistent with the gastrulation defect I observe. The muscle-specific MyoD  was 
unaffected by the presence or absence of ISWI, supporting the hypothesis that the 
primary role of ISWI is in the development of neural tissue.
ISWI binds directly to the BMP4 promoter
Consistent with the down-regulation of neural genes, expression of BMP4  was 
increased approximately 2-fold in anti-/.SW  morpholino-injected embryos (figure 3). 
Reduced BM P activity has been shown to induce anterior-neural tissue from non-neural 
ectoderm (Harland 1997; Harland and Gerhart 1997). BMP4 is normally down-regulated 
in neural tissue in order for neurulation to begin. Since ISWI has been implicated in both 
activation and repression of genes, I wished to test whether ISWI is directly targeted to 
the BMP4 promoter, where it could act as a repressor in neural tissues. I therefore used 
chromatin immunoprecipitation (ChIP) analysis to detect ISWI protein at BM P4 .1 used 
the anti-ISWI antibody to immunoprecipitate cross-linked, sheared chromatin, and 
measured the enrichment of BMP4 or control sequences (MYOD) using slot blots. 
Representative blots are shown in figure 3C, and the average enrichment o f ISWI at 
BMP4 is shown in Figure 3D. ISWI protein is detected at BMP4 in vivo (figure 3C, left) 
consistent with a direct role for ISWI in BMP4  regulation. In contrast, no ISWI is 
detected at the MyoD  gene, the expression of which is unaffected by the presence or 
absence of ISWI (figure 3A-B). Furthermore, the BMP4  signal is lost in anti-ISWI 
morpholino-injected embryos. These results strongly suggest that ISWI acts as a 
repressor of BMP4 in neural tissue. This analysis was performed in whole embryos;
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ChlPs of neural vs. non-neural tissue will help confirm whether ISWI is a repressor of 
BMP4 in neural tissue or an activator of BMP4 in other tissues.
A Dominant-Negative ISWI mutant also inhibits development
Antisense interference using direct injection of antisense RNA or morpholinos is 
a powerful method for functional inhibition of a target gene in all tissues in early 
development. However, it is more difficult to target injected antisense/morpholinos to 
specific tissues. I have developed a dominant-negative mutant of xISWI, DN-ISWI, which 
can ultimately be placed under the control of tissue-specific or inducible promoters in 
transgenic frogs. I identified the invariant lysine in the ISWI ATPase domain (K612) and 
mutated it to an alanine (figure 4A). The mutation was confirmed through sequencing and 
the plasmid was named ISWI-K612A. Mutation of this conserved lysine has been used to 
create catalytically inactive mutants of yeast SWI2 (Khavari 1993; Richmond and 
Peterson 1996) and human B rg l and hbrm  (de la Serna et al. 2001) These ATPase_ 
mutants assemble into remodeling complexes, competing with the wildtype ATPase for 
complex assembly. To confirm that the ISWI-K612A mutant behaves as a dominant 
negative in Xenopus embryos, I tested whether the presence of the mutant ISW I in early 
embryos could recapitulate the phenotype I observed in the antisense/morpholino 
experiments. A 3500bp DN-ISWI transcript was produced using the T7 promoter and a 
poly-A tail was added for better translation efficiency. A GFP  transcript was also
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SANT
xISWI NGILADEMGLGKTLQTISLL hSNF2H NGILADEMGLGKTLQTISLL hSNF2L NGILADEMGLGKTLQTIALL dmISWI NGILADEMGLGKTLQTISLL
B C D
Figure 3.4 An ATPase mutant of ISWI acts as a dominant negative in vivo. A. The conserved lysine in the 
Xenopus ISWI ATPase domain, which is essential for ISWI’s catalytic activity, was located and mutated to 
an alanine. An alignment of Xenopus, human, and Drosophila ISWI homologs shows the relevant region, 
with the invariant lysine (K) shown in red. B. Injection of 1 ng/nl DN-ISWI mRNA recapitulates the 
gastrulation defect observed in antisense- or anti-ISWI morpholino-injected embryos (bottom panel). Top 
panel shows a control embryo injected with 1 ng/nl GFP mRNA. C. Failure of brain development in DN- 
ISWI mRNA-injected embryo (bottom); compare to stage 45 embryo from same egg clutch injected with 
GFP mRNA (top). D. Cataract development in stage 43 embryo injected with DN-ISWI mRNA (bottom; 
gray spot in center of eye); control GFP mRNA-injected embryo is shown above.
synthesized as a control for the effects of injecting any tailed mRNA. After injection of 
DN-ISW I or GFP  mRNA, embryos were allowed to develop at 16°C.
Injection of the DN-ISW I mutant mRNA results in gastrulation and neural fold 
phenotypes that are indistinguishable from those observed in the antisense- and 
morpholino-injected embryos (figure 4B). DN-ISWI protein is strongly expressed in 
embryos as measured by Western analysis (data not shown). To show that DN-ISW I is in 
fact acting as a dominant negative, I performed a rescue experiment in which wild-type 
ISW I mRNA was coinjected with the DN-ISW I mRNA, in order to provide more wild 
type ISWI to compete with the dominant negative mutant. The neural phenotype caused 
by the injection of DN-ISW I can be rescued by co-injection with wild type ISW I mRNA 
(table I). Coinjection of 1 ng/nl DN-ISW I + 0.5 ng/nl wild type ISW I resulted in a two 
fold-reduction of the mutant phenotype to only 43% of the injected embryos, compared to 
a neural phenotype in 80% of the embryos injected with D N-ISW I alone. Coinjection of 1 
ng/nl of both DN-ISW I and wild type ISW I reduces the neural phenotype to only 33% of 
the injected embryos. It is also important to note that the fact that DN-ISWI causes the 
same phenotypes as inhibition of ISWI suggests that it is the chromatin 
remodeling/ATPase activity per se of ISWI that is critical for its function in development.
As I observed with antisense RNA and morpholino injections, injection of lower 
concentrations of DN-ISWI mRNA permitted a number of embryos to survive the early 
gastrulation defects, allowing us to detect phenotypes at later stages. Comparable to the 
morpholino-injected embryos, DN-ISWI mRNA-injected embryos exhibit a spectrum of 
defects in brain and eye development. These include extreme developmental delays in
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eye development: for example, at stages 35-38, ISW I-deficient embryos had small, 
flattened lenses still attached to the overlying ectoderm (separation normally occurs at 
stage 33), resembling lens placodes as normally seen at stage 25-26. Another dramatic 
phenotype is shown in Figure 4C. Some embryos injected with DN-ISWI mRNA exhibit a 
catastrophic failure of forebrain development, coupled with malformed eyes that are 
mislocalized to the central axis of the animal, essentially occupying the space created by 
the reduction of forebrain tissue.
ISWI-deficient embryos develop posterior subcapsular cataracts and have defects in 
retinal differentiation
Late stage survivors of DN-ISW I mRNA injections develop a striking phenotype 
at approximately stage 38/40: the development of congenital cataracts in the vast majority 
of the survivors (figure 4D; table II). This phenotype also occurs in anti-ISWI 
morpholino-injected embryos; in some batches of injected embryos every survivor 
eventually developed clouded lenses, while the cataract phenotype never appeared in 
control injections (table II). In addition, these embryos appear to be blind, in that they are 
unresponsive to shadows or objects moving above them, stimuli that cause control 
embryos to swim rapidly away from the objects, substantiating the extent of these lens 
and retinal defects. The cataractous embryos do, however, respond to currents or touch, 
consistent with specific visual impairment.
There are many different types of congenital cataracts, such as those identified in 
humans (Amaya et al. 2003). We therefore initiated a collaboration with Dr. Jonathan 
Henry (University of Illinois Urbana) to perform histological analyses to further
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characterize the specific eye defects in the ISW I-deficient embryos. Sections from both 
control and anti-ISWI morpholino-injected embryos at stages 38 and 45 are shown in 
figure 5A-F. The cataractous lenses exhibit abnormal cell proliferation on the posterior 
surface, leading to the accumulation of large densely stained, basophilic cells (figure 6E, 
asterisk) resulting in a form of posterior subcapsular cataract and a severe lenticonus 
condition. Liquefied, apoptotic cells also appear to be present.
In general the ISWI morpholino knockdown eyes appear to be retarded in their 
development when compared to control eyes. Anti-ISWI morpholino-injected embryos 
exhibit defects in retinal differentiation, and cell adhesion (compare figure 5A,C to D,F). 
younger stage 38 eye cups appear to have many loose rounded cells. Some cells in the 
younger embryos also appear to be picnotic, highly condensed, fragmented and apoptotic 
(figure 5D). Later defects are also apparent. For instance, cells of the ganglion layer do 
not appear to be arranged in a single layer (figure 5E-F). These cells are also closely 
associated with the lens, which is normally well separated at this time (compare figure 5B 
and E). There is no clear distinction of the inner and outer nuclear layers nor the 
formation of a thin outer plexiform layer (compare figure 5C and F).
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Figure 3.5 Cross sections through normal control and defective eyes in ISWI morpholino knockdown 
embryos. A. Normal stage 38 eye showing optic cup, lens and cornea. Note presence of large central, 
primary lens fiber cell “nucleus” and additional secondary lens fiber cells at the periphery of the lens. B-C. 
Corresponding high and low magnification views of the normal eye in a stage 45 animal. Note large mass 
of enucleated lens fiber cells and thin nucleated lens epithelium. Also note normal arrangement of 
differentiated cell layers within the eye cup. D. Stage 38 ISWI morpholino knockdown eye. Note that the 
lens is more poorly developed compared to (A) and contains a much smaller mass of primary lens fiber 
cells. Other lens and retinal cells appear to be more highly rounded. E-F. Corresponding high and low 
magnification views of the stage 45 ISWI morpholino knockdown eye. Note presence of large basophilic, 
nucleated cell mass (cataract) on the posterior surface of the lens (asterisk). Defects are also apparent in the 
development of the retinal layers (see text for further details). Cn, cornea; gn, ganglion layer; in, inner 
nuclear layer; ip, inner plexiform layer; le, lens epithelium; If lens fiber cells; In, lens; oc, optic cup; on, 
outer nuclear layer; op, outer plexiform layer; os, rod and cone outer segments; pr, pigmented retinal 
epithelium. Scale bar equals 25 pm  for A-B and D-E, 50 jim for C and F.
Furthermore, the rod and cone outer segments appear to be poorly developed in ISWI 
knockdown animals. Frequently I observed that the retinal pigmented epithelium is 
detached from the rod and cone outer segments, suggesting that there may be other 
changes in cell adhesion, as well (compare figure 5C and F).
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Discussion
Imitation Switch and Xenopus laevis
I have shown that Xenopus ISW I mRNA is located specifically in neural tissue, 
including brain, neural fold, hypaxial muscle, the optic vesicle and cup, auditory vesicles 
and spinal cord. Early inhibition of ISWI protein production causes a lethal phenotype of 
incomplete gastrulation and neurulation. The mRNA levels of the neural-specific genes 
Xmeis, shh, slug, sox9, Pax6, and Hoxb9 are greatly reduced in embryos injected with 
antisense ISW I RNA or anti-/SW7 morpholino, while the muscle-specific gene M yoD  is 
unaffected. However, the mRNA of BMP4, a gene normally down-regulated in neural 
tissue as neurulation begins, is over-expressed in ISW I-deficient embryos. I propose that 
ISWI may normally facilitate the formation of neural tissue by repressing genes that 
inhibit neural tissue such as BMP4, which is supported by the fact that ISWI binds 
directly to the BMP4 gene in vivo, and this interaction is perturbed upon injection of anti- 
ISW I morpholino. This model does not exclude an additional role for ISWI in activating 
genes that specify neural tissue development. It is possible that ISWI has multiple neural- 
specific gene targets and is continuously required throughout development.
The knockdown of ISWI also results in the formation of congenital cataracts.
ISWI is not normally expressed in the lens ectoderm. Hence, I surmise that these 
cataracts are due to the retarded and abnormal development of the retinal tissues in these 
embryos, leading to abnormal induction of the lens, and possibly to the inadequate 
production of key growth factors required to sustain normal lens development and 
differentiation. These lens defects could also stem from abnormal planar induction of the
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placodal ectoderm during the early phase of lens induction (Henry and Grainger 1990) 
These effects may be directly or indirectly related to the abnormal regulation of BMP4 
expression in the neural ectoderm, or to other key genes involved in controlling and 
patterning eye development such as Pax6 or shh. (Crossley et al. 2001; Zuber et al.
2003). For instance, it is known that BMP4 plays a key role in eye development and lens 
induction (Furuta and Hogan 1998). It is also known that BMP4 regulates cell 
proliferation and apoptosis in the brain and optic cup (Trousse et al. 2001).
I have created a functional dominant-negative ISWI mutant, which will be an 
excellent tool to dissect ISWI function, by interfering with ISWI function at specific 
times or in specific tissues during development. By placing DN-ISWI under control of 
neural-specific promoters, for example, I can test the role of ISWI in specific neural 
pathways.
This study has focused on the role of ISWI, which is involved in at least four 
different complexes in Xenopus. Ultimately, we hope to determine which of these ISWI 
complexes are responsible for the specific defects I observed by targeting subunits unique 
to each complex, using the methods described in this work. These future experiments will 
allow us to examine the specific interactions of chromatin remodelers and their targets 
during neural development in Xenopus.
Chromatin remodeling and neural development
Chromatin remodeling complexes are often thought of as ubiquitous factors that 
control the expression of large numbers of genes. It is therefore somewhat surprising to 
find that so many remodeling complexes appear to be specific for neural tissue, including
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Xenopus, human, murine and Drosophila ISWI homologs. In addition to the ISWI 
complexes, other SWI2/SNF2 family members appear to be critical in neural 
development. The human CHD5 remodeler is localized in neural tissue and is suspected 
to play a role in embryonic development (Thompson et al. 2003). BAF53b, part of the 
human SW I/SNF remodeling complex, is localized in postmitotic neurons and may create 
neuronal-specific patterns of chromatin accessibility (Olave et al. 2002). BAF57, a 
Xenopus SW I/SNF subunit, works in conjunction with Xsmad7 to increase expression of 
neural markers in Xenopus ectodermal explants (Domingos et al. 2002). Numerous 
SW I2/SNF2 family members exhibit neural expression patterns in Xenopus (Linder et al.
2004). Finally, the human SNF2L complex hNURF is enriched in the brain and regulates 
human Engrailed, a homeodomain protein that regulates neuronal development in the 
mid-hindbrain (Barak et al. 2003).
ISWI is turning out to be a surprisingly diverse subfamily of the SNF2 
superfamily. Drosophila has three ISW I-containing complexes, yeast and Xenopus have 
four, and mammals appear to have seven distinct ISWI complexes. ISWI-containing 
complexes tend to have fewer subunits (2-4) relative to SNF2 subfamily containing 
complexes (~12). In biochemical assays, SNF2-subfamily complexes tend to disrupt 
nucleosome structure, while ISWI-subfamily complexes have been observed to enhance 
chromatin structure by equalizing nucleosome spacing, and to assemble nucleosomes 
(Lusser and Kadonaga 2003). ISWI also has a unique requirement for histone tails for 
nucleosome remodeling (Clapier et al. 2002). Recently the crystal structure of the 
nucleosome recognition module of ISWI was determined and an ISW I-specific DNA
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binding domain called SLIDE, in a region essential for H4 binding, was identified 
adjacent to the SANT domain (Grune et al. 2003). It is clear from many studies how 
important ISW I-containing complexes are to the development and/or function of each 
organism in which these complexes have been described. Each chromatin-remodeling 
complex, despite the similarities of their biochemical activities in vitro, may have far 
more specialized roles in gene expression and other cellular functions than previously 
suspected.
Why so many ISWI complexes?
The ISWI family is unique among the SWI2/SNF2 superfamily for the sheer 
diversity of different complexes. ISWI complexes are generally small (2-5 subunits) 
compared to other SWI2/SNF2 complexes such as SWI/SNF, RSC, or NuRD, which 
have on the order of 8-15 subunits. (The only large ISWI complex, in fact, is the ISWI- 
cohesin complex, which gets most of its bulk from NuRD.) Why pack every subunit you 
could ever need into a single massive SWI/SNF complex, while spreading ISWI out into 
3-7 different complexes, many of which barely deserve the name “complex?” (Two- 
subunit complexes are sometimes called heterodimers).
There seem to be two key differences between the ISWI family and most of the 
other ATP-dependent remodelers: the diversity of functions performed and the 
differences in targeting. M ost of the other ATP-dependent remodelers that have been 
characterized seem to function primarily in transcription, either activation or repression. 
Different remodelers regulate different sets of genes, which leads to different biological 
outcomes, but the basic function remains the same. The vast numbers of subunits are
65
responsible for targeting of the complexes to all the sites of action, and for interacting 
with other factors needed for the transcriptional control, such as histone modifying 
complexes and basal transcription machinery.
For ISWI complexes, transcriptional regulation represents only a subset of the 
roles that must be satisfied. Many of the roles performed by ISWI complexes don’t 
require site-specific targeting at all: replication and chromatin assembly occur 
everywhere, roles in transcriptional elongation may apply to many or all genes, cohesin 
loading is likely to have only minor sequence specificity at most, and global changes in 
chromosome structure are not likely to be mediated site-directed targeting of ISWI. ISWI 
shows up in pericentric heterochromatin, telomeric chromatin, and the nucleolus. These 
may all represent examples of targeting to structures rather than sequences. O f course, 
some ISWI complexes are likely to have site-specific roles, particularly those that are 
involved in transcriptional regulation of particular genes, such as NURF.
In a sense, ISWI is an all-purpose tool that can be tossed into many different 
toolboxes. All ISWI containing complexes share the ability to slide nucleosomes, a clear 
biological function of ISWI in vitro (Langst and Becker 2001a; Langst and Becker 
2001b; Kang et al. 2002; Kassabov 2002 Nov; Flaus and Owen-Hughes 2003; Kukimoto 
et al. 2004) that has also been detected in vivo (Fazzio and Tsukiyama 2003). ISWI can 
be fitted with different handles, such as a subunit to interact with the replication 
machinery or a subunit or two to recognize an elongating RNA polymerase. We have 
seen ISWI appear in a complex with cohesin and NuRD; we may find that other
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remodelers or histone modifiers occasionally have a use for ISWI as well. The count is 
up to 19, how many more places will we find ISWI in the future?
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Appendix A
In situ hybridization controls
Figure B .l Representative negative controls for in situ hybridization. This group represents embryos incubated with ISWI sense strand digoxygenin labeled probe. A-B: stage 10/12, C: stage 25/26, E: approximately stage 30.
